Epigenetic silencing of the tumor-suppressing gelsolin gene involves histone deacetylation of its promoter region in human urinary bladder cancer

被引：0
|
作者：
Haga K. [1 ,2 ]
Fujita H. [1 ]
Sazawa A. [1 ,2 ]
Takimoto M. [1 ]
Shinohara N. [2 ]
Koyanagi T. [2 ]
Kuzumaki N. [1 ]
机构：
[1] Division of Cancer Gene Regulation, Institute for Genetic Medicine, Hokkaido University, Hokkaido
[2] Department of Urology, School of Medicine, Hokkaido University, Hokkaido
来源：
Nature Genetics | 2001年 / 27卷 / Suppl 4期
关键词：
D O I：
10.1038/87162
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：66 / 66
相关论文
共 38 条
  • [21] Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer
    Fukuhara, H
    Kuramochi, M
    Fukami, T
    Kasahara, K
    Furuhata, N
    Nobukuni, T
    Maruyama, T
    Isogai, K
    Sekiya, T
    Shuin, T
    Kitamura, T
    Reeves, RH
    Murakami, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (06): : 605 - 609
  • [22] Epigenetic regulation of the human Wnt7a gene in non-small cell lung cancer cells involves both DNA methylation and histone modifications
    Jo, Uk Hyun
    Joo, Hyun Jung
    Park, Kyong Hwa
    Kim, Yeul Hong
    CANCER RESEARCH, 2009, 69
  • [23] Mycobacteria inhibition of IFN-γ induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells
    Wang, Y
    Curry, HM
    Zwilling, BS
    Lafuse, WP
    JOURNAL OF IMMUNOLOGY, 2005, 174 (09): : 5687 - 5694
  • [24] Evaluation of methylation pattern in promoter region of E-cadherin gene and its relation to tumor grade and stage in breast cancer
    Shargh, Shohreh A.
    Sakizli, Meral
    Farajnia, Safar
    Montazer-Saheb, Soheila
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (10): : 1745 - 1751
  • [25] Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
    Jürgen Veeck
    Erik Noetzel
    Nuran Bektas
    Edgar Jost
    Arndt Hartmann
    Ruth Knüchel
    Edgar Dahl
    Molecular Cancer, 7
  • [26] Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
    Veeck, Juergen
    Noetzel, Erik
    Bektas, Nuran
    Jost, Edgar
    Hartmann, Arndt
    Knuechel, Ruth
    Dahl, Edgar
    MOLECULAR CANCER, 2008, 7 (1)
  • [27] Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer
    Kwong, Joseph
    Lee, Ji-Young
    Wong, Kwong-Kwok
    Zhou, Xiaofeng
    Wong, David T. W.
    Lo, Kwok-Wai
    Welch, William R.
    Berkowitz, Ross S.
    Mok, Samuel C.
    NEOPLASIA, 2006, 8 (04): : 268 - 278
  • [28] Therapy of murine bladder cancer with tumor-specific suicide gene expression driven by human telomerase reverse transcriptase promoter in syngeneic mouse tumor model
    Shieh, GS
    JOURNAL OF UROLOGY, 2003, 169 (04): : 188 - 188
  • [29] Epigenetic inactivation of the candidate tumor suppressor gene RRP22 on 22q12.2 by means of promoter hypermethylation and histone modifications in diffusely infiltrating human gliomas
    Schmidt, N.
    Reifenberger, G.
    Riemenschneider, M. J.
    BRAIN PATHOLOGY, 2010, 20 : 50 - 50
  • [30] Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells
    Saito, Yoshimasa
    Friedman, Jeffrey M.
    Chihara, Yoshitomo
    Egger, Gerda
    Chuang, Jody C.
    Liang, Gangning
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (03) : 726 - 731
1234